[go: up one dir, main page]

DK0941081T3 - Ny anvendelse af creatin - Google Patents

Ny anvendelse af creatin

Info

Publication number
DK0941081T3
DK0941081T3 DK97951157T DK97951157T DK0941081T3 DK 0941081 T3 DK0941081 T3 DK 0941081T3 DK 97951157 T DK97951157 T DK 97951157T DK 97951157 T DK97951157 T DK 97951157T DK 0941081 T3 DK0941081 T3 DK 0941081T3
Authority
DK
Denmark
Prior art keywords
creatine
new use
new
Prior art date
Application number
DK97951157T
Other languages
Danish (da)
English (en)
Inventor
Marco Anelli
Ettore Strumia
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11375243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0941081(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Application granted granted Critical
Publication of DK0941081T3 publication Critical patent/DK0941081T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK97951157T 1996-11-19 1997-11-10 Ny anvendelse af creatin DK0941081T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI002408A IT1298420B1 (it) 1996-11-19 1996-11-19 Uso della creatina nell'insufficienza cardio-respiratoria
PCT/EP1997/006225 WO1998022099A2 (fr) 1996-11-19 1997-11-10 Nouvelle utilisation de la creatine

Publications (1)

Publication Number Publication Date
DK0941081T3 true DK0941081T3 (da) 2003-04-22

Family

ID=11375243

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97951157T DK0941081T3 (da) 1996-11-19 1997-11-10 Ny anvendelse af creatin

Country Status (13)

Country Link
US (1) US6242490B1 (fr)
EP (1) EP0941081B1 (fr)
CN (2) CN1237904A (fr)
AR (1) AR009425A1 (fr)
AT (1) ATE230983T1 (fr)
BR (1) BR9713514A (fr)
DE (1) DE69718506T2 (fr)
DK (1) DK0941081T3 (fr)
ES (1) ES2191206T3 (fr)
IT (1) IT1298420B1 (fr)
PT (1) PT941081E (fr)
RU (1) RU2202345C2 (fr)
WO (1) WO1998022099A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3384539B2 (ja) * 1997-09-05 2003-03-10 義之 内田 喘息治療剤
EP1051914A1 (fr) * 1999-05-08 2000-11-15 DSM Fine Chemicals Austria GmbH Utilisation de la créatine comme additif pour l'alimentation animale
US20030212130A1 (en) * 2000-09-14 2003-11-13 Miller Donald W. Creatine ester anti-inflammatory compounds and formulations
US20030212136A1 (en) * 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
US9833427B2 (en) 2000-09-14 2017-12-05 Board Of Regents Of The University Of Nebraska Creatine ester anti-inflammatory compounds and formulations
US20040052852A1 (en) * 2001-09-25 2004-03-18 Michael Farber Carbohydrate-based delivery system for creatine and other bioactive ingredients
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
US20060025475A1 (en) * 2004-07-29 2006-02-02 Stanley Antosh Use of methyl pyruvate for the purpose of increasing muscle energy production.
US20060052448A1 (en) * 2004-09-04 2006-03-09 Mr. Stanley Antosh Use of methyl pyruvate or methyl pyruvic acid for the treatment of diseases of the nervous system and for protecting a human central nervous system against neuronal degeneration caused by defective intracellular energy production.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244534B1 (fr) * 1973-06-27 1977-07-01 Biotherax Lab
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
US5470838A (en) * 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
AU3086897A (en) * 1996-06-28 1998-01-21 Ipr-Institute For Pharmaceutical Research Ag Drug preparations, containing creatine with at least one salt of calcium, magnesium, manganese or zinc

Also Published As

Publication number Publication date
BR9713514A (pt) 2000-02-29
RU2202345C2 (ru) 2003-04-20
ITMI962408A1 (it) 1998-05-19
EP0941081B1 (fr) 2003-01-15
ATE230983T1 (de) 2003-02-15
CN1237904A (zh) 1999-12-08
PT941081E (pt) 2003-04-30
ES2191206T3 (es) 2003-09-01
EP0941081A2 (fr) 1999-09-15
WO1998022099A3 (fr) 1998-07-09
US6242490B1 (en) 2001-06-05
AR009425A1 (es) 2000-04-12
WO1998022099A2 (fr) 1998-05-28
IT1298420B1 (it) 2000-01-05
DE69718506D1 (de) 2003-02-20
ITMI962408A0 (it) 1996-11-19
DE69718506T2 (de) 2003-07-31
CN1623534A (zh) 2005-06-08

Similar Documents

Publication Publication Date Title
NO993068L (no) Ny forbindelsesform
DK0914103T3 (da) Behandling af hæmoglobinopati
NO982414D0 (no) Ny kombinasjon
ID23338A (id) Popok tarik sekali pakai
BR9704713A (pt) Combinação estabilizadora
ID17499A (id) Alat suntik
NO20001830D0 (no) Ny kombinasjon
ID23198A (id) Popok tarik sekali pakai
NO993298D0 (no) Ny fremgangsmÕte
DK0941081T3 (da) Ny anvendelse af creatin
DK1702623T3 (da) Anvendelse af interferon-gamma til behandling af hjertehypertrofi
NO995796D0 (no) Ny fremgangsmåte
FI956015L (fi) 5-asyyli-1,4-dihydropyridiinien käyttö
DE59705708D1 (de) Lagebestimmung von peripherieeinheiten
DK0689577T3 (da) Anvendelse af ferroncen
NO985084D0 (no) Vial
DE69733607D1 (de) Herstellung von cycloalkyldiarylphosphinen
DK0927163T3 (da) Fremstilling af 1-butyl-4-piperidinylmethylamin
FR2744447B1 (fr) Utilisation de derives de tetrahydroisoquinoleine
ID17383A (id) Penggunaan terbaru turunan turunan sistina
NO993069D0 (no) Ny anvendelse av dipeptider
FI974235A0 (fi) Ny bestaemningsmetod
DK0913063T3 (da) Validering af procedurer
KR970053863U (ko) 콤파스기능을 갖는 자
KR970062700U (ko) 락킹 홀더의 구조